Form 4: Liquidia Chief Accounting Officer Sells Shares for Tax Obligations Under 10b5-1 Plan
Insider Transaction Report
Liquidia Corp's Chief Accounting Officer, Dana Boyle, sold 1,193 shares of common stock at $14.28 per share on July 14, 2025, to cover tax liabilities related to restricted stock unit settlements.
Summary
- Dana Boyle, Chief Accounting Officer of Liquidia Corp (LQDA), executed a sale of 1,193 shares of common stock.
- The transaction occurred on July 14, 2025, with shares sold at a price of $14.28 per share.
- The purpose of the sale was to cover taxes associated with the settlement of restricted stock units (RSUs).
- The sale was conducted pursuant to a Rule 10b5-1 plan, which was adopted by Dana Boyle on December 15, 2023.
- Following this transaction, Dana Boyle beneficially owns 187,168 shares of Liquidia Corp common stock.
- The beneficial ownership includes 2,826 unvested RSUs from a January 16, 2022 grant, 21,875 unvested RSUs from a January 25, 2023 grant, 35,678 unvested RSUs from a January 11, 2024 grant, 50,861 unvested RSUs from a January 11, 2025 grant, 25,000 unvested RSUs from a July 1, 2025 grant, and 11,029 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The transaction is a routine tax-related sale by an executive, which is a common practice and does not indicate a change in company fundamentals or management's view of the company's prospects. It is neutral in sentiment.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- Shares were sold to cover taxes associated with the settlement of restricted stock units (RSUs).
Industry Context
This Form 4 filing details a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies. It does not provide information relevant to broader industry trends or competitive dynamics within the biotechnology or pharmaceutical sectors.
Stakeholder Impact
- Shareholders: The transaction represents a minor reduction in insider ownership, but it is a routine tax-related sale and is unlikely to significantly impact shareholder sentiment or company valuation.
- Employees: The transaction is specific to executive compensation and does not directly impact the broader employee base.
Key Dates
| Date | Description |
|---|---|
| 01/16/2022 | Grant date for 15,075 RSUs to the Reporting Person. |
| 01/25/2023 | Grant date for 50,000 RSUs to the Reporting Person. |
| 12/15/2023 | Rule 10b5-1 plan adopted by the Reporting Person. |
| 01/11/2024 | Grant date for 57,085 RSUs to the Reporting Person. |
| 01/11/2025 | Grant date for 50,861 RSUs to the Reporting Person. |
| 07/01/2025 | Grant date for 25,000 RSUs to the Reporting Person. |
| 07/14/2025 | Transaction date for the sale of 1,193 shares of common stock. |
| 07/15/2025 | Signature date of the Form 4 filing. |
Recommendation
holdKeywords
Liquidia Corp, LQDA, Form 4, insider trading, stock sale, RSU, restricted stock units, 10b5-1 plan, executive compensation, tax obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.